Hysterectomy
Methodology & AI Transparency ⓘ
Hysterectomy Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: What is a hysterectomy? A hysterectomy is surgery to remove the uterus (womb).
- 2 Real-world patient consensus: Mapped to PCOS, Endometriosis & Gynecologic Health under ICD-10-CM N81.5 for Hysterectomy clinical workups.
- 3 Typical cash cost range: Differential triage of Hysterectomy (N81.5) utilizes minimally invasive gynecologic in Hysterectomy (N81.5: care).
- 4 Top reported side effects / signs: Longitudinal Hysterectomy monitoring tracks CBC & Serum in Hysterectomy (N81.5: Ferritin (heavy bleeding)) toward Ferritin > 50 ng/mL (N81.5).
Ask our AI Specialists anything about Hysterectomy
What Is Hysterectomy?
What is a hysterectomy? A hysterectomy is surgery to remove the uterus (womb). The uterus is the place where a fetus grows during pregnancy. A hysterectomy treats problems like heavy bleeding, pain, or cancer in the uterus. After a hysterectomy, you no longer have menstrual periods and can't become pregnant. Sometimes the surgery also removes the ovaries and fallopian tubes. If you have both ovaries taken out, menopause symptoms will usually begin. What conditions does a hysterectomy treat? Hysterectomy is a major surgery. Your health care provider may suggest other treatment options first.
Pathophysiology, Underlying Causes & Clinical Presentation
In Hysterectomy (N81.5), physiological disruption stems from reduced hepatic SHBG in Hysterectomy (N81.5: (in PCOS)), Cross-referenced with NIH MeSH (Hysterectomy), informing PCOS, Endometriosis & Gynecologic Health protocols that track LH, FSH & in Hysterectomy (N81.5: Prolactin) (Normal ovulatory endocrine axis (N81.5)).
Common Symptoms & Clinical Signs
- • Fibroids , if you are near or past menopause, have large fibroids or very heavy bleeding
- • Endometriosis , that hasn't been cured by medicine or surgery
- • Presentation of Hysterectomy (N81.5): hyperandrogenic acne along in Hysterectomy (N81.5: the jawline, hirsutism,)
- • Secondary Hysterectomy clinical sign: pelvic pressure, bloating, in Hysterectomy (N81.5: or pain radiating)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Hysterectomy Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | N81.5 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | PCOS, Endometriosis & Gynecologic Health | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: CBC & Serum in Hysterectomy (N81.5: Ferritin (heavy bleeding)) | Ferritin > 50 ng/mL (N81.5) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: LH, FSH & in Hysterectomy (N81.5: Prolactin) | Normal ovulatory endocrine axis (N81.5) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Free & Total in Hysterectomy (N81.5: Testosterone + SHBG) | Sex-specific physiological range (N81.5) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Hysterectomy
Treatment selection for Hysterectomy depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Hysterectomy)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on [Comment] Preserving the uterus: an effective dual therapy to avoid Endometrial ablation offers an effective, uterus-sparing alternative for women who do not desire future childbearing, with lower perioperative morbidity and faster recovery than hysterectomy.1–3 However, the durability of this... The Lancet • 2026-10-21 • Peer-Reviewed Journal (Clinical Trials) | Multi-cohort | 95/100 | PMID LANCET-2824242815 ↗ |
| Can This Approach Help? Inside the Latest Research on Benefits and safety of co-crystal of tramadol-celecoxib (CTC) in acute Although the study did not meet its primary endpoint, CTC 200 mg showed a clinically relevant improvement in overall. European journal of pain (London, England) • 2022-11-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 35974668 ↗ |
| Can This Approach Help? Inside the Latest Research on Investigating the effects of estradiol or estradiol/progesterone treatment on The two hormones, however, had no effects on mood, well-being, menopausal symptoms, sleep quality and depressive symptoms. Neuropsychobiology • 2005-01-15 • Randomized Controlled Trial | Multi-cohort | 88/100 | PMID 15942259 ↗ |
| New Insights on Chemoradiotherapy With or Without Simultaneous Integrated Boost for Cervical: What a 466-Participant Study Found A total of 466 patients with cervical cancer presenting with FT or OFT stromal invasion after radical hysterectomy were randomized (233 in non-SIB radiotherapy group: median age, 53 years [IQR, 46-59 years]; 233 in SIB... JAMA network open • 2025-09-02 • Phase III Randomized Trial | N = 466 | 87/100 | PMID 40971156 ↗ |
| Can This Approach Help? Inside the Latest Research on Comparative outcomes of simple versus radical hysterectomy in patients with and There were similar recurrence and survival outcomes but less morbidity from SH compared to RH in patients with and without very low-risk early-stage cervical cancer from the SHAPE trial. Gynecologic oncology • 2026-02-15 • Phase III Randomized Trial | N = 107 | 82/100 | PMID 41520567 ↗ |
Hysterectomy Patient Community & “People Like Me” Threads
Filter Hysterectomy community threads and patient logs by age, biological sex, dosage, and treatment duration.